Schedule of Business Segment Information |
The Company’s business segment information was as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
Proteomics |
|
$ |
28,209 |
|
|
$ |
18,088 |
|
|
$ |
64,389 |
|
|
$ |
33,288 |
|
Genomics |
|
|
8,996 |
|
|
|
9,578 |
|
|
|
18,356 |
|
|
|
19,497 |
|
Total revenue |
|
$ |
37,205 |
|
|
$ |
27,666 |
|
|
$ |
82,745 |
|
|
$ |
52,785 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations: |
|
|
|
|
|
|
|
|
|
|
|
|
Proteomics |
|
$ |
(23,739 |
) |
|
$ |
(3,710 |
) |
|
$ |
(38,275 |
) |
|
$ |
(9,191 |
) |
Genomics |
|
|
952 |
|
|
|
(437 |
) |
|
|
756 |
|
|
|
(260 |
) |
Corporate expenses |
|
|
(19,201 |
) |
|
|
(11,035 |
) |
|
|
(43,204 |
) |
|
|
(21,174 |
) |
Restructuring and related charges |
|
|
(5,749 |
) |
|
|
(2,267 |
) |
|
|
(10,033 |
) |
|
|
(3,417 |
) |
Transaction and integration expenses |
|
|
(2,782 |
) |
|
|
— |
|
|
|
(19,945 |
) |
|
|
— |
|
Total income (loss) from operations |
|
$ |
(50,519 |
) |
|
$ |
(17,449 |
) |
|
$ |
(110,701 |
) |
|
$ |
(34,042 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation & amortization: |
|
|
|
|
|
|
|
|
|
|
|
|
Proteomics |
|
|
1,896 |
|
|
|
3,240 |
|
|
$ |
5,253 |
|
|
$ |
6,512 |
|
Genomics |
|
|
346 |
|
|
|
164 |
|
|
|
747 |
|
|
|
330 |
|
Corporate |
|
|
1,614 |
|
|
|
222 |
|
|
|
3,050 |
|
|
|
446 |
|
Total depreciation & amortization |
|
$ |
3,856 |
|
|
$ |
3,626 |
|
|
$ |
9,050 |
|
|
$ |
7,288 |
|
|